Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Omni Health Inc | 1.1K | 0.0x | --- |
Gelstat Corp | 157.5K | -0.1x | --- |
Lucy Scientific Discovery Inc | 10.6K | 0.0x | --- |
Nxgen Brands Inc | 18.3K | --- | --- |
Oncology Pharma Inc | 3.9K | 0.0x | --- |
SymBio Pharmaceuticals Ltd | 71.5M | -2.0x | --- |
Omni Health, Inc. is an integrated healthcare company. The Company is focused on the development of pharmaceuticals, anti-aging products, and biotech engineering. The Company’s subsidiary is Malecon Pharmacy, Inc., which is engaged in healthcare services and operates in the lucrative pharmaceutical, medical and wellness industries.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1K |
---|---|
Revenue (TTM) | $3.4M |
Shares Outstanding | 1.1B |
Omni Health Inc does not pay a dividend. | |
Beta | --- |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -13.23% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.